Company / Operating Income
ABEONA THERAPEUTICS INC. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$89.4M
FY2025
5-year range
-$89.8M / -$47.1M
FY2021-FY2025
Trend
-89.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has fluctuated over the past 10 years, ranging from -$90M in FY2022 to -$19M in FY2016.
Based on SEC 10-K filings.
-$89M in FY2025.
Declined from -$51M to -$89M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income decreased 89.8% year-over-year.
- Peak operating income was recorded in FY2016.
- Lowest operating income in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$89.4M | -89.8% |
| FY2024 | -$47.1M | +7.4% |
| FY2023 | -$50.9M | +43.3% |
| FY2022 | -$89.8M | -10.3% |
| FY2021 | -$81.4M | -5.6% |
| FY2020 | -$77.1M | -176.9% |
| FY2019 | -$27.8M | +52.1% |
| FY2018 | -$58.2M | -109.0% |
| FY2017 | -$27.8M | -50.1% |
| FY2016 | -$18.5M | -492.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026